{"id":980569,"date":[{"year":1995,"month":3,"day":25}],"page":"5","source":"本报","region":"纽约","masthead":"国际新闻·连载","special_issue":"","column":"","genre":"","count":"252","ytitle":"争论多年有了结果","mtitle":"水痘疫苗获准在美上市","ftitle":"","authors":["张焕培"],"text":[{"type":"paragraph","text":"本报纽约3月24日电　(记者张焕培)据《纽约时报》报道，经过多年争议和拖延之后，美国联邦食品和药物管理署于17日批准水痘疫苗上市。至此，美国所有主要儿童传染性疫病都有了相关的疫苗可控制。"},{"type":"paragraph","text":"美国儿科学会建议为一岁以上的儿童全面接种这种水痘疫。虽然有效率仅在70%-90%之间，但凡接种过的人即使感染水痘，病情会大为减轻。另一个缺点是，接种疫苗后，注射的地方会出现红肿和硬块，还使人产生疲倦和要呕吐的感觉。已上市的这种疫苗名为Varivax，每剂39美元。"}]}